LABATEC Women Health and Mithra announce the successful launch of Myloop® in Switzerland

Published on 9 June 2021



LABATEC WOMEN HEALTH AND MITHRA ANNOUNCE THE SUCCESSFUL LAUNCH OF MYLOOP® IN SWITZERLAND

A hormonal contraceptive ring

 

Geneva, 10th of June 2021 – LABATEC successfully launches a contraceptive vaginal ring – MyLoop® manufactured by our partner Mithra.

About MyLoop®

This contraceptive vaginal ring is a generic of NuvaRing®. This medicine will be marketed as MyLoop®, in the form of a vaginal ring containing 11.7mg of Etonogestrel and 2.7mg of Ethinylestradiol. This generic has a shelf-life of 36 months can be stored at room temperature.

About Labatec

A Swiss based privately owned pharmaceutical company, based in Meyrin (Geneva) since 1957, Labatec develops and markets medicines that contribute to improve patients quality of life. Our portfolio includes more than 60 high quality products, manufactured in Europe and Canada. Labatec is a recognized partner choice for Swiss hospitals (anti-infectious, anaesthetic, antiemetic and oncological products) and has an established retail presence in the therapeutic categories of osteoporosis, muscle relaxants and women’s health. In the women’s health segment, our strategy is to offer a wide range of contraceptives at affordable prices for patients.
For more information, please visit http://www.labatecpharma.com/

About Mithra

Mithra (Euronext: MITRA) is a Belgian biotech company dedicated to transforming Women’s Health by offering new choices through innovation, with a particular focus on contraception and menopause. Mithra’s goal is to develop products offering better efficacy, safety and convenience, meeting women’s needs throughout their life span. Mithra explores the potential of Estetrol, a unique native oestrogen in a wide range of applications in women’s health and beyond (covid-19, neuroprotection,…). Mithra also develops and manufactures complex therapeutics in the areas of contraception, menopause and hormone-dependent cancers. It offers partners a complete spectrum of research, development and specialist manufacturing at its technological platform Mithra CDMO. Active in more than 100 countries around the world, Mithra has an approximate headcount of 300 staff members and is headquartered in Liège, Belgium. www.mithra.com

Contact for more information
myloop@labatec.com
Labatec Pharma SA, 1217 Meyrin (GE)


Get in touch

Would you like to discuss a collaboration or partnership project? Get in touch with us at partnering@labatec.com or connect with us at one of the upcoming events.

For other enquiries, please visit our contact page.